AIIMS Delhi To Start Second Dose Trial Of Bharat Biotech’s Covaxin On 2-6 Years Old Children

New Delhi, July 22: All India Institute of Medical Sciences in New Delhi will commence the second dose trial of Bharat Biotech's COVID-19 vaccine, Covaxin, for children aged 2-6 years.

Additionally, the results of clinical trials are expected to come in one month after the completion of trials of all age groups. 

 

Comments

Cross Town News is the no. 1 Weekly Newspaper and Online News Portal in J&K in term of serious News. The rugged Newspaper & Portal is with a substantial difference to read and presence to feel. This newspaper has a vision to deliver the real side of truth to the public . Since it’s inception in 2013 March, It has become No. 1 News medium for people of J&K. Cross Town News has a mission to deliver high quality news across the nation within fraction of time.

Subscribe Now

Subscribe to our weekly Newsletter.